How has LifeStance Health Group's accrued manufacturing costs changed year-over-year?

LifeStance Health Group's accrued manufacturing costs increased by 17.4% year-over-year, from $99.92M to $117.31M.

What is the long-term trend for LifeStance Health Group's accrued manufacturing costs?

Over 5 years (2020 to 2025), LifeStance Health Group's accrued manufacturing costs has grown at a 30.4% compound annual growth rate (CAGR), from $38.02M to $143.33M.

LifeStance Health Group LFST Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Acadia HealthcareACHC

——

Encompass Health CorporationEHC

——

Medpace Holdings, Inc.MEDP

——

Universal Health ServicesUHS

——

Hims & Hers HealthHIMS

——

ExlService HoldingsEXLS

——

Other financials

Income statement

See full

Revenue$403.5M+21.2%

Operating income$22.3M+1,289%

Net income$14.2M+1,909%

EPS (diluted)$0.04—

Balance sheet

See full

Cash & equivalents$194.8M+45.0%

Total debt$476.8M-1.1%

Total equity$1.5B+1.4%

Total assets$2.1B+2.0%

Cash flow

See full

Operating cash flow$33.1M+1,171%

CapEx$10.8M+50.2%

Free cash flow$22.3M+318%

Valuation

See full

Market cap$3.6B-4.8%

Profitability

See full

Operating margin3%+2.4pp

Net margin1.6%+1.0pp

FCF margin9.5%+1.6pp

Returns & leverage

See full

Return on equity1.6%+1.0pp

Debt / equity0.3×0.0×

Current ratio1.5×0.0×

Where this comes from

Reported directly by LifeStance Health Group in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: LifeStance Health Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeStance Health Group's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LifeStance Health Group's accrued manufacturing costs?: LifeStance Health Group (LFST) reported accrued manufacturing costs of $117.31M in Q1 2026.
How has LifeStance Health Group's accrued manufacturing costs changed year-over-year?: LifeStance Health Group's accrued manufacturing costs increased by 17.4% year-over-year, from $99.92M to $117.31M.
What is the long-term trend for LifeStance Health Group's accrued manufacturing costs?: Over 5 years (2020 to 2025), LifeStance Health Group's accrued manufacturing costs has grown at a 30.4% compound annual growth rate (CAGR), from $38.02M to $143.33M.